Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Limited Target Volume Radiotherapy After Glioblastoma Surgery [NA]
This clinical trial is studying limited target volume radiotherapy after glioblastoma surgery and is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids [Phase 2]
ARISTOCRAT is a Phase 2 blinded trial evaluating temozolomide with or without cannabinoids in glioblastoma, currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Venous Thromboembolism Prevention in Outpatients With Glioma [Phase 2]
A Phase 2 clinical trial is updating recruitment status for venous thromboembolism prevention in outpatients with glioma, including glioblas…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma [Phase 1]
A Phase 1 trial evaluating CAR T cells targeting MMP2 in patients with recurrent or progressive glioblastoma; the study is currently active …
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma [Phase 1]
Phase 1 clinical trial evaluating GPC-3–targeted CAR T cells in adults with recurrent GPC-3–positive glioblastoma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Prospective Cohort of Patients With Newly Diagnosed Glioblastoma: Analysis of MMP2 and MMP9 Expression and Correlation to Neuro-imaging Features. [NA]
This clinical trial update describes a prospective cohort study in patients with newly diagnosed glioblastoma examining MMP2 and MMP9 expres…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Tumor Hypoxia and Proliferation in Patients With High-Grade Glioma [Phase 1]
Phase 1 trial evaluating tumor hypoxia and proliferation in high-grade glioma has been suspended. Sponsor: Weill Medical College of Cornell …
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma [NA]
Ongoing clinical trial evaluating intensity-modulated stereotactic radiotherapy for patients with grade II–IV gliomas, including glioblastom…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB) [Phase 2]
Phase 2 clinical trial evaluating BPM31510 with Vitamin K1 in newly diagnosed glioblastoma; the study is currently active but not recruiting…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Leica Microsystems Sponsored PMCF Study to Collect and Confirm Clinical Data on the Performance of the GLOW400 Device When Used in Accordance With Its Intended Use
Leica Microsystems has initiated a post-market clinical follow-up study to collect data on the performance of the GLOW400 device when used a…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Irinotecan-ChemoSeed in Surgically Resectable Glioblastoma [Phase 2]
A Phase 2 clinical trial update for Irinotecan-ChemoSeed in surgically resectable glioblastoma; the study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed Glioblastoma [Phase 2]
This clinical trial update reports a Phase 2 study evaluating a neoantigen-pulsed autologous dendritic cell vaccine in combination with temo…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: MRinRT: Swansea University and SWWCC Collaboration Study.
The MRinRT Swansea University and SWWCC collaboration study updates on MRI-guided adaptive radiotherapy and is not yet recruiting, with mult…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: LITT Followed by Hypofractionated RT for Recurrent Gliomas [NA]
Clinical trial evaluating laser interstitial thermal therapy (LITT) followed by hypofractionated radiation therapy for recurrent gliomas; re…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Effect of Salovum® on Pressure, Oxygen and Inflammation in Glioblastoma [Phase 2]
A Phase 2 clinical trial is evaluating Salovum for effects on brain pressure, oxygenation, and inflammation in glioblastoma, currently recru…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM [Phase 1]
A Phase I clinical trial update for CB-NK-TGF-ßR2-/NR3C1- therapy in recurrent gliosarcoma and recurrent supratentorial glioblastoma, curren…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma [Phase 1]
This document describes a phase 1 clinical trial to evaluate the safety of a stem cell-based gene and cell therapy in patients with newly di…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Study of Pembrolizumab and M032 (NSC 733972) [Phase 1, Phase 2]
A Phase 1/2 clinical trial update evaluating pembrolizumab in combination with M032 for glioblastoma, anaplastic astrocytoma, and gliosarcom…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: 5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the combination of Avutometinib and Defactinib in malignant brain tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: 131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2) [Phase 1]
Phase 1 study update on 131I-TLX-101 for newly diagnosed glioblastoma; the trial is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Study of Low-Intensity Focused Ultrasound in Combination With Immunotherapy in Newly Diagnosed Unmethylated Glioblastoma [Phase 1]
A Phase 1 study evaluating the combination of low-intensity focused ultrasound with immunotherapy for newly diagnosed unmethylated glioblast…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN). [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating PLB1001 enteric capsules for IDH-mutant glioblastoma with ZM fusion in glioblastoma patients; the stud…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBM [Phase 1, Phase 2]
The document reports that a Phase 1/2 clinical trial evaluating Exablate-enabled disruption of the blood-brain barrier with Carboplatin for …
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Key Longitudinal Associations With Risk and Glioblastoma Outcomes
The document provides an update on a recruiting clinical trial studying longitudinal associations with risk and outcomes in glioblastoma, sp…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors [NA]
This ClinicalTrials.gov entry describes a study testing a customized neuro-imaging referenced symptom video intended to reduce patient and c…